An Open-label, Non-controlled Study of KHK4827 in Subjects With Psoriasis
NCT01782937
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
30
Enrollment
INDUSTRY
Sponsor class
Conditions
Psoriasis
Interventions
DRUG:
KHK4827
Sponsor
Kyowa Kirin Co., Ltd.